Search Results - "Azzalini, L"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2

    Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis by Lirussi, F, Azzalini, L, Orando, S, Orlando, R, Angelico, F

    Published in Cochrane database of systematic reviews (24-01-2007)
    “…Non-alcoholic fatty liver disease (NAFLD) is characterised by fatty deposition in the hepatocytes of patients with minimal or no alcohol intake and without…”
    Get more information
    Journal Article
  3. 3

    Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis by Orlando, R, Azzalini, L, Orando, S, Lirussi, F

    Published in Cochrane database of systematic reviews (24-01-2007)
    “…Non-alcoholic fatty liver disease is a condition characterised by fatty deposition in the hepatocytes of patients in patients with minimal or no alcohol…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Outcomes of chronic total occlussion recanalization in patients with prior bypass-surgery: an updated systematic review and meta-analysis of real world registries by Romeo, F, Moroni, F, Del Buono, M G, Damonte, J I, Chiabrando, J G, Azzalini, L

    Published in European heart journal (09-11-2023)
    “…Abstract Background Recanalization of chronic total occlusion (CTO) coronary lesions by percutaneous coronary intervention (PCI) in patients with prior…”
    Get full text
    Journal Article
  9. 9

    Coronary perforations and its clinical impact during CTO recanalization: a 2054 patients pooled analysis from the Latin American (LATAM) CTO registry by Harada Ribeiro, M, Quadros, A, Padilla, L T, Belli, K C, Piccaro, P, Dallan, L A, Silveira, C E, Quesada, F H, Morales, N, Santiago, R, Mashayekhi, K C, Azzalini, L A, Galassi, A R, Campos, C M

    Published in European heart journal (12-10-2021)
    “…Abstract Introduction Percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) are the most challenging procedures and still associated with…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Contrast-induced nephropathy: An update by Spagnoli, V, Azzalini, L, Tadros, V X, Picard, F, Ly, H Q

    Published in Annales de cardiologie et d'angeiologie (01-04-2016)
    “…Contrast-induced nephropathy (CIN) is common in hospitalized patients. Its occurrence is associated with an increased hospitalization stay and cost, morbidity…”
    Get more information
    Journal Article
  12. 12

    Néphropathie induite par les produits de contraste : une mise à jour by Spagnoli, V., Azzalini, L., Tadros, V.X., Picard, F., Ly, H.Q.

    Published in Annales de cardiologie et d'angéiologie (01-04-2016)
    “…La néphropathie induite par les produits de contraste (NIPC) représente une complication fréquente chez les patients hospitalisés. Sa survenue est associée à…”
    Get full text
    Journal Article
  13. 13